BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7683585)

  • 21. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leukopenia.
    Watanabe Y; Kikuchi R; Kiriyama M; Nakagawa K; Oe J; Nomura H; Maruyama K; Matsumoto M
    Biol Pharm Bull; 1995 Aug; 18(8):1084-8. PubMed ID: 8535401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
    Toyama K; Yaguchi M; Mizoguchi H; Masuda M; Urabe A; Ikeda Y; Aoki I; Shinbo T; Togawa A; Hirashima K; Miura Y; Hirose S; Tsuruoka N; Omine M; Kamakura M; Saito T; Arimori S; Aoki N; Kuraishi Y; Hirai H; Asano S; Mori M; Shirai T; Muto Y; Takaku F
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1242-53. PubMed ID: 9011117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
    Iwase M; Yoshiya M; Kakuta S; Nagumo M
    J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis.
    Zuppa AA; Girlando P; Florio MG; Cota F; Romagnoli C; Tortorolo G
    Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):131-6. PubMed ID: 11950479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of HS 6101 and rhG-CSF on Hematopoiesis Recovery of ICR Mice Injured by Cyclophosphamide].
    Xiong GL; Shen X; Liu XL; Yang M; Dai CL; Liu XY; Xing S; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1716-20. PubMed ID: 26708899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.
    Bermudez LE; Martinelli JC; Gascon R; Wu M; Young LS
    Cytokine; 1990 Jul; 2(4):287-93. PubMed ID: 1966550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Tamura M; Hattori K; Nomura H; Ono M; Yokota T
    Infect Immun; 1987 Nov; 55(11):2715-20. PubMed ID: 2444540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic activity (leukopoietic effect) of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after rectal administration in rabbits with leukopenia induced by cyclophosphamide.
    Watanabe Y; Kiriyama M; Oe J; Kikuchi R; Mizufune Y; Matsumoto M
    Biol Pharm Bull; 1996 Aug; 19(8):1064-7. PubMed ID: 8874817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
    Okabe M; Saiki I; Nakane K; Miyazaki T
    Rinsho Byori; 1992 Apr; 40(4):397-402. PubMed ID: 1375667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
    Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination effect of KW-2228 and aminoglycoside antibiotics on systemic infection in cyclophosphamide-treated tumor-bearing mice].
    Yoshino T; Sato K
    Jpn J Antibiot; 1992 Jan; 45(1):98-105. PubMed ID: 1379653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.